Jump to content
RemedySpot.com

Xoma Stops Work on Experimental Hepatitis Drug

Rate this topic


Guest guest

Recommended Posts

Guest guest

Xoma Stops Work on Experimental Hepatitis Drug

East Bay Business Times - Jul. 31, 2006

Xoma Ltd. said late Friday it stopped work on an experimental hepatitis B

drug after the company that developed it backed out of a research deal.

Berkeley-based Xoma (NASDAQ: XOMA) was working with Cubist Pharmaceuticals

Inc. (NASDAQ: CBST) on the drug HepeX-B, but said Cubist stopped its

investment in the project because of stringent Food and Drug Administration

requirements. Xoma and Cubist made a deal in September 2005 in which Xoma

worked to find new ways of manufacturing HepeX-B.

Xoma has notified Cubist that it will terminate their contract, although the

two companies are discussing other options for the drug. HepeX-B has been

granted Orphan Drug Status by both European and American regulators.

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1024652 & contentty\

pe=sentryarticle & channelID=31

_________________________________________________________________

On the road to retirement? Check out MSN Life Events for advice on how to

get there! http://lifeevents.msn.com/category.aspx?cid=Retirement

Link to comment
Share on other sites

Guest guest

Xoma Stops Work on Experimental Hepatitis Drug

East Bay Business Times - Jul. 31, 2006

Xoma Ltd. said late Friday it stopped work on an experimental hepatitis B

drug after the company that developed it backed out of a research deal.

Berkeley-based Xoma (NASDAQ: XOMA) was working with Cubist Pharmaceuticals

Inc. (NASDAQ: CBST) on the drug HepeX-B, but said Cubist stopped its

investment in the project because of stringent Food and Drug Administration

requirements. Xoma and Cubist made a deal in September 2005 in which Xoma

worked to find new ways of manufacturing HepeX-B.

Xoma has notified Cubist that it will terminate their contract, although the

two companies are discussing other options for the drug. HepeX-B has been

granted Orphan Drug Status by both European and American regulators.

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1024652 & contentty\

pe=sentryarticle & channelID=31

_________________________________________________________________

On the road to retirement? Check out MSN Life Events for advice on how to

get there! http://lifeevents.msn.com/category.aspx?cid=Retirement

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...